Robert Bradway named president and COO at Amgen
This article was originally published in Scrip
Amgen has named Robert Bradway president and chief operating officer, effective 11 May. He will report to the company's chairman and CEO, Kevin Sharer, and will be responsible for global commercial operations, manufacturing operations, strategy & corporate development, IT, global government affairs and compliance. Mr Bradway has served as Amgen's executive vice-president and chief financial officer since April 2007, having joined the company in 2006 as vice-president of operations strategy. Before that, he was a managing director at Morgan Stanley in London, where he was responsible for the firm's banking department and corporate finance activities in Europe. Michael Kelly, Amgen's vice-president of finance and chief accounting officer, will serve as acting CFO, effective 11 May. He joined Amgen in 2003 and has served as chief accounting officer since 2005. Amgen also announced that its executive vice-president of global commercial operations, George Morrow, is to retire on 31 January 2011.